Inhaled Dry Powder Formulations for Treating Tuberculosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|12|1|26-39

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.12, Iss.1, 2015-02, pp. : 26-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low powder mass filling of dry powder inhalation formulations

By Eskandar Fadi   Lejeune Morgane   Edge Stephen  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 1, 2011-01 ,pp. : 24-32

Informa Healthcare

Access to resources Recommend Favorite

Powder Production and Particle Engineering for Dry Powder Inhaler Formulations

By  

Current Pharmaceutical Design, Vol. 21, Iss. 27, 2015-01 ,pp. : 3902-3916

Bentham Science Publishers

Access to resources Recommend Favorite

Liquid-Spray or Dry-Powder Systems for Inhaled Delivery of Peptide and Proteins?

By Garcia-Contreras Lucila   Smyth Hugh D.C.  

American Journal of Drug Delivery, Vol. 3, Iss. 1, 2005-01 ,pp. : 29-45

Adis International

Access to resources Recommend Favorite

Temozolomide-Based Dry Powder Formulations for Lung Tumor-Related Inhalation Treatment

By Wauthoz Nathalie   Deleuze Philippe   Saumet Amandine   Duret Christophe   Kiss Robert   Amighi Karim  

Pharmaceutical Research, Vol. 28, Iss. 4, 2011-04 ,pp. : 762-775

Springer Publishing Company

Access to resources Recommend Favorite

Stabilization of Proteins in Dry Powder Formulations Using Supercritical Fluid Technology

By Jovanović Nataša   Bouchard Andréanne   Hofland Gerard W.   Witkamp Geert-Jan   Crommelin Daan J. A.   Jiskoot Wim  

Pharmaceutical Research, Vol. 21, Iss. 11, 2004-11 ,pp. : 1955-1969

Springer Publishing Company

Access to resources Recommend Favorite